The immune system is capable of identifying and attacking cancer cells in the body. This process depends on the tumor producing…
LIXT is advancing its lead compound LB-100 across different clinical programs aimed at difficult-to-treat cancers The company’s acquisition of Liora…
LIXT is advancing its lead candidate LB-100, a first-in-class therapy designed to enhance the effectiveness of existing cancer treatments The…
The shares of health insurers in the U.S. recorded gains after the Trump administration announced 2027 payment rate increases for Medicare Advantage that were higher than…
Cancer research often relies on massive and complex datasets, which can take time and effort to sift through manually. The…
Researchers at the University of Calgary in Canada are conducting further trials after early studies revealed that vitamin B3, or niacin, holds…
According to a poll conducted by Gallup in March, Americans are most concerned about healthcare. This finding is notable given the…
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)and may include paid advertising. The company has appointed Chilean drug…
A recently published report by Mordor Intelligence analyzes future projections, growth drivers and the key trends that are shaping the…
Publishing research in peer-reviewed journals plays a central role in ensuring the credibility and reliability of scientific findings. Companies that…